3Leavy CM ,Sherlock S,Tygstrup N ,des. Diseases of the liver and billiarg tract-standardization of nomenclature diagnostic criteria and prognosis. New York: Raven Press,1994. 165.
4Liver Cancer study Group of Japan. Survey and followup study of primary liver career in Japan- repart 11. Acta Hepatol Jpn, 1995,36:208.
5Parker SL, Tong T,Boldens, et al. Cancer statistics. Cancer J Glin,1997,45:5.
6Anna CH. Ras - proto - oncogene activation in dichloroacetic acid triehoroethylene and tetra-chloroethylene-induced liver tumors in Boc3F1 mice Carcinogenesis. 1994,15 : 2255.
7Soiniy, Chia SL, Bennett, et al. An aflatoxin -- associated hotspot at codon 249 in the P53 tumor suppressor gene Occurs in hepatocellular carcinomas from mexico. Carcinogenesis,1996,17 : 1007.
8MarxJ. New tumor supressor may rival P53. Science, 1994,264 : 344.
9Marakmi Y, Hoyashi K, Hironashi S, et al. Aberation of tumor suppressor P53 and retinolastoma genes in human hepatoeellalar carcinoma. Cancer Res, 1991,51:5520.
10Chen Y,kayano T,Takagi M. Dysregulated expression of bcl-2 and bax in oral carcinomas .evidence of post-tran-scriptional control. J Oral Pathol Med, 2000,29(2) : 63-69.
